Schonfeld Strategic Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
76,897
+54,647
| +246% | +$1.51M | 0.01% | 869 |
|
|
2025
Q1 | $631K | Sell |
22,250
-45,542
| -67% | -$1.29M | ﹤0.01% | 1367 |
|
|
2024
Q4 | $2.82M | Buy |
67,792
+49,953
| +280% | +$2.08M | 0.02% | 654 |
|
|
2024
Q3 | $1.19M | Sell |
17,839
-120,723
| -87% | -$8.07M | 0.01% | 975 |
|
|
2024
Q2 | $16.5M | Buy |
138,562
+125,877
| +992% | +$14.9M | 0.11% | 184 |
|
|
2024
Q1 | $1.35M | Sell |
12,685
-2,011
| -14% | -$214K | 0.01% | 953 |
|
|
2023
Q4 | $1.46M | Sell |
14,696
-3,323
| -18% | -$330K | 0.01% | 842 |
|
|
2023
Q3 | $1.86M | Buy |
+18,019
| New | +$1.86M | 0.01% | 737 |
|
|
2023
Q1 | – | Sell |
-39,264
| Closed | -$7.05M | – | 2330 |
|
|
2022
Q4 | $7.05M | Sell |
39,264
-12,623
| -24% | -$2.27M | 0.06% | 390 |
|
|
2022
Q3 | $6.14M | Buy |
51,887
+43,538
| +521% | +$5.15M | 0.05% | 458 |
|
|
2022
Q2 | $1.19M | Sell |
8,349
-2,155
| -21% | -$308K | 0.01% | 872 |
|
|
2022
Q1 | $1.81M | Buy |
10,504
+8,838
| +530% | +$1.52M | 0.02% | 727 |
|
|
2021
Q4 | $423K | Sell |
1,666
-3,034
| -65% | -$770K | ﹤0.01% | 1279 |
|
|
2021
Q3 | $1.81M | Sell |
4,700
-30,352
| -87% | -$11.7M | 0.02% | 688 |
|
|
2021
Q2 | $8.24M | Buy |
+35,052
| New | +$8.24M | 0.09% | 309 |
|
|
2021
Q1 | – | Sell |
-2,410
| Closed | -$252K | – | 1954 |
|
|
2020
Q4 | $252K | Buy |
+2,410
| New | +$252K | ﹤0.01% | 1227 |
|
|
2020
Q2 | – | Sell |
-7,436
| Closed | -$223K | – | 1401 |
|
|
2020
Q1 | $223K | Buy |
+7,436
| New | +$223K | 0.01% | 872 |
|